Frederick, Maryland, United States
AstraZeneca Decentralized Material
AstraZeneca modified its bulk cell culture manufacturing campus located in Frederick, Maryland. Lendlease provided construction management services for the Decentralized Material Control program. The program scope included modifying existing facilities and infrastructure on campus to support the continued manufacturing growth at the campus.
Project outcome
The program included renovations in four distinct project areas:
- B633 Weigh and Dispense
- B630 GPF and BDS
- B633 Shipping and Receiving Expansion / Segregation
- B660 QC Raw Materials Laboratory